101 related articles for article (PubMed ID: 9481010)
1. Proteolysis associated with insulin resistance in cystic fibrosis.
Hardin DS; LeBlanc A; Lukenbaugh S; Para L; Seilheimer DK
Pediatrics; 1998 Mar; 101(3 Pt 1):433-7. PubMed ID: 9481010
[TBL] [Abstract][Full Text] [Related]
2. Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis.
Hardin DS; LeBlanc A; Para L; Seilheimer DK
Diabetes; 1999 May; 48(5):1082-7. PubMed ID: 10331413
[TBL] [Abstract][Full Text] [Related]
3. Insulin regulation of free fatty acid kinetics in adult cystic fibrosis patients with impaired glucose tolerance.
Moran A; Basu R; Milla C; Jensen MD
Metabolism; 2004 Nov; 53(11):1467-72. PubMed ID: 15536603
[TBL] [Abstract][Full Text] [Related]
4. Elevated gluconeogenesis and lack of suppression by insulin contribute to cystic fibrosis-related diabetes.
Hardin DS; Ahn C; Rice J; Rice M; Rosenblatt R
J Investig Med; 2008 Mar; 56(3):567-73. PubMed ID: 18418124
[TBL] [Abstract][Full Text] [Related]
5. Protein metabolism in clinically stable adult cystic fibrosis patients with abnormal glucose tolerance.
Moran A; Milla C; Ducret R; Nair KS
Diabetes; 2001 Jun; 50(6):1336-43. PubMed ID: 11375334
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance is associated with decreased clinical status in cystic fibrosis.
Hardin DS; LeBlanc A; Lukenbough S; Seilheimer DK
J Pediatr; 1997 Jun; 130(6):948-56. PubMed ID: 9202618
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of insulin resistance in cystic fibrosis.
Hardin DS; Leblanc A; Marshall G; Seilheimer DK
Am J Physiol Endocrinol Metab; 2001 Nov; 281(5):E1022-8. PubMed ID: 11595659
[TBL] [Abstract][Full Text] [Related]
8. The metabolic effects of pregnancy in cystic fibrosis.
Hardin DS; Rice J; Cohen RC; Ellis KJ; Nick JA
Obstet Gynecol; 2005 Aug; 106(2):367-75. PubMed ID: 16055589
[TBL] [Abstract][Full Text] [Related]
9. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
Hammana I; Malet A; Costa M; Brochiero E; Berthiaume Y; Potvin S; Chiasson JL; Coderre L; Rabasa-Lhoret R
Diabetes Metab; 2007 Jun; 33(3):213-9. PubMed ID: 17418606
[TBL] [Abstract][Full Text] [Related]
10. Proinsulin, insulin, and C-peptide in cystic fibrosis after an oral glucose tolerance test.
Hartling SG; Garne S; Binder C; Heilmann C; Petersen W; Petersen KE; Koch C
Diabetes Res; 1988 Apr; 7(4):165-9. PubMed ID: 3042255
[TBL] [Abstract][Full Text] [Related]
11. Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis.
Tofé S; Moreno JC; Máiz L; Alonso M; Escobar H; Barrio R
Eur J Endocrinol; 2005 Feb; 152(2):241-7. PubMed ID: 15745932
[TBL] [Abstract][Full Text] [Related]
12. Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis.
Ahmad T; Nelson R; Taylor R
Metabolism; 1994 Feb; 43(2):163-7. PubMed ID: 8121296
[TBL] [Abstract][Full Text] [Related]
13. Identification of insulin secretory defects and insulin resistance during oral glucose tolerance test in a cohort of cystic fibrosis patients.
Battezzati A; Mari A; Zazzeron L; Alicandro G; Claut L; Battezzati PM; Colombo C
Eur J Endocrinol; 2011 Jul; 165(1):69-76. PubMed ID: 21502328
[TBL] [Abstract][Full Text] [Related]
14. Reduced pancreatic insulin release and reduced peripheral insulin sensitivity contribute to hyperglycaemia in cystic fibrosis.
Holl RW; Heinze E; Wolf A; Rank M; Teller WM
Eur J Pediatr; 1995 May; 154(5):356-61. PubMed ID: 7641765
[TBL] [Abstract][Full Text] [Related]
15. Increased glucose excursion in cystic fibrosis and its association with a worse clinical status.
Costa M; Potvin S; Hammana I; Malet A; Berthiaume Y; Jeanneret A; Lavoie A; Lévesque R; Perrier J; Poisson D; Karelis AD; Chiasson JL; Rabasa-Lhoret R
J Cyst Fibros; 2007 Nov; 6(6):376-83. PubMed ID: 17409029
[TBL] [Abstract][Full Text] [Related]
16. No changes of insulin sensitivity in cystic fibrosis patients with different degrees of glucose tolerance: an epidemiological and longitudinal study.
Cucinotta D; De Luca F; Gigante A; Arrigo T; Di Benedetto A; Tedeschi A; Lombardo F; Romano G; Sferlazzas C
Eur J Endocrinol; 1994 Mar; 130(3):253-8. PubMed ID: 8156098
[TBL] [Abstract][Full Text] [Related]
17. Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance.
Sheikh S; Gudipaty L; De Leon DD; Hadjiliadis D; Kubrak C; Rosenfeld NK; Nyirjesy SC; Peleckis AJ; Malik S; Stefanovski D; Cuchel M; Rubenstein RC; Kelly A; Rickels MR
Diabetes; 2017 Jan; 66(1):134-144. PubMed ID: 27495225
[TBL] [Abstract][Full Text] [Related]
18. A Transient Metabolic Recovery from Early Life Glucose Intolerance in Cystic Fibrosis Ferrets Occurs During Pancreatic Remodeling.
Yi Y; Sun X; Gibson-Corley K; Xie W; Liang B; He N; Tyler SR; Uc A; Philipson LH; Wang K; Hara M; Ode KL; Norris AW; Engelhardt JF
Endocrinology; 2016 May; 157(5):1852-65. PubMed ID: 26862997
[TBL] [Abstract][Full Text] [Related]
19. Glucose tolerance and insulin receptor binding to monocytes and erythrocytes in patients with cystic fibrosis.
Andersen O; Garne S; Heilmann C; Petersen KE; Petersen W; Koch C
Acta Paediatr Scand; 1988 Jan; 77(1):67-71. PubMed ID: 3285636
[TBL] [Abstract][Full Text] [Related]
20. The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis.
Coriati A; Ziai S; Lavoie A; Berthiaume Y; Rabasa-Lhoret R
Acta Diabetol; 2016 Jun; 53(3):359-66. PubMed ID: 26215312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
